Impact of AI-Powered Decision Support Systems on Clinical Results in Oncology: A Meta-Analysis

A wide range of medical domains, including imaging diagnosis, Pathological classification, choosing a treatment strategy, and prognostic evaluation, have made extensive use of artificial intelligence (AI). Human-computer cooperation has reached a mature state, particularly in image-aided tumour diagnosis. IBM's Watson system has been used in a variety of industries, including banking, tourism, medical care, education, fashion, and law. Particularly in area of cancer, Watson for Oncology (WFO, IBM Corporation, USA), the first commercially available CDSS, has progressively gained international recognition in the disciplines like lung, colon, rectal, gynaecological, breast, and gastric cancer. The medical personnel just needs to enter the case's structured data based on the WFO system. The algorithm will provide the most common course of therapy for the particular situation in less than a minute and produce very reliable proof.